SCHEMBL6788209

SCHEMBL6788209

COc1ccc(-c2cccc3[nH]c4cnn(C)c4c(=O)c23)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.42
ATM Q13315 2/20 0.40
PRMT5 O14744 2/20 0.37
WDR77 Q9BQA1 2/20 0.37
MAP2K1 Q02750 1/20 0.37
GAA P10253 2/20 0.37
MEN1 O00255 1/20 0.37
MAPT P10636 1/20 0.37
KMT2A Q03164 1/20 0.37
HIF1A Q16665 1/20 0.37
HDAC4 P56524 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
MCHR1 Q99705 1/20 0.36
KDM4E B2RXH2 4/20 0.36
ALDH1A1 P00352 4/20 0.36
HPGD P15428 3/20 0.36
GLA P06280 1/20 0.36
CASP1 P29466 1/20 0.36
HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6784780 0.89 PRMT5 (0.44) PRMT5WDR77GAAMEN1MAPT
SCHEMBL6784727 0.86 KDR (0.43) PARP1ATMPRMT5WDR77MAP2K1
SCHEMBL6782186 0.86 CDK4 (0.38) PARP1GAAHIF1A
Hydrochloric Acid SCHEMBL6785628 0.85 KDR (0.42) PARP1ATMPRMT5WDR77MAP2K1
SCHEMBL6784847 0.79 CDK4 (0.39) PARP1MAP2K1GAA
SCHEMBL6788043 0.75 FEN1 (0.42) PARP1ATMMAP2K1GAAMEN1
SCHEMBL6785738 0.74 POLB (0.39) ATMPRMT5WDR77GAAMEN1
SCHEMBL6785377 0.74 PRMT5 (0.47) ATMPRMT5WDR77GAAKDM4E
SCHEMBL14255815 0.73 ABCG2 (0.56) GAAMEN1MAPTKMT2AKDM4E
SCHEMBL6781822 0.73 DAO (0.34) PARP1ATMGAAHIF1AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6686373-B2 ANALGESICS; ANTIINFLAMMATORY AGENT WARNER-LAMBERT COMPANY LLC 2004-02-03 US disclosed
US-20030130277-A1 Pyrazoloquinolinone derivatives as protein kinase C inhibitors KAWAMURA KIYOSHI (JP) 2003-07-10 US disclosed
EP-1310498-A2 Pyrazoloquinolinone derivatives as protein kinase C inhibitors PFIZER INC. (US) 2003-05-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030130277-A1 Pyrazoloquinolinone derivatives as protein kinase C inhibitors PRKCB, PRKCA, PRKCG PARP1 2711/4885ATM 591/4885PRMT5 612/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.